These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10626149)

  • 1. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
    Bladé J; Kyle RA
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.
    Bladé J; Lust JA; Kyle RA
    J Clin Oncol; 1994 Nov; 12(11):2398-404. PubMed ID: 7964956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual myelomas: a review of IgD and IgE variants.
    Pandey S; Kyle RA
    Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of nonsecretory multiple myeloma presenting as primary plasma cell leukemia.
    Takahashi T; Kanno S; Itoh H; Yoshimoto M; Tsujisaki M; Fujino M
    Intern Med; 2014; 53(18):2121-5. PubMed ID: 25224200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
    Pruzanski W; Rother I
    Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literature.
    Tokunaga T; Hashimoto H; Yoshida Y; Sugimoto T; Mokuda S; Kosaka Y; Shimizu R; Hirata S; Kumagai T; Komoto K; Wada H; Sugiyama E
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):22-28. PubMed ID: 32985955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgD-kappa myeloma with unusual manifestations: an exceptional form].
    Kanoh T
    Tohoku J Exp Med; 1987 Aug; 152(4):347-50. PubMed ID: 3116721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple myeloma with D immunoglobulin].
    Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
    Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
    Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
    Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
    Morris C; Iacobelli S; Gahrton G; van Biezen A; Drake M; Garderet L; Potter M; Schattenberg AV; Cornelissen JJ; Hamladji RM; Martelli M; Petersen E; Rovira M; Bandini G; Kroger N; de Witte T
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1054-8. PubMed ID: 25708221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgD myeloma: clinical, biological and laboratory features.
    Sinclair D
    Clin Lab; 2002; 48(11-12):617-22. PubMed ID: 12465746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin D multiple myeloma in our hospital--a rare occurrence.
    Tan LK; Suri R; Lim HL; Ong SK
    Singapore Med J; 2000 Oct; 41(10):500-3. PubMed ID: 11281443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa and lambda light chain disease: survival rates and clinical manifestations.
    Shustik C; Bergsagel DE; Pruzanski W
    Blood; 1976 Jul; 48(1):41-51. PubMed ID: 820387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in IgD myeloma: a study of 21 cases.
    Fibbe WE; Jansen J
    Scand J Haematol; 1984 Nov; 33(5):471-5. PubMed ID: 6515330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma.
    Sharma A; Binazir T; Sintow A; Lee CC; Shaharyar S; Tache J
    Cureus; 2017 Jun; 9(6):e1400. PubMed ID: 28845377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
    García-Sanz R; Orfão A; González M; Tabernero MD; Bladé J; Moro MJ; Fernández-Calvo J; Sanz MA; Pérez-Simón JA; Rasillo A; Miguel JF
    Blood; 1999 Feb; 93(3):1032-7. PubMed ID: 9920853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.